COCH Envoy Medical, Inc.
Healthcare$0.70-1.27%ClosedMarket Cap: $14.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.63
P/S
63.02
EV/EBITDA
0.41
DCF Value
$0.03
FCF Yield
-140.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
-310.7%
Operating Margin
-9881.2%
Net Margin
-9875.6%
ROE
239.4%
ROA
-77.5%
ROIC
-130.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $39.0K | -702.6% | $-6.0M | $-4.4M | $— | — |
| Q4 null | $75.0K | -181.3% | $-6.4M | $-6.6M | $— | — |
| FY null | $241.0K | -262.7% | $-22.3M | $-23.8M | $— | — |
| Q3 null | $42.0K | -383.3% | $-5.7M | $-6.5M | $— | — |
| Q2 null | $78.0K | -200.0% | $-5.1M | $-5.7M | $— | — |
| Q1 null | $46.0K | -391.3% | $-5.1M | $-5.0M | $— | — |
| Q4 null | $42.0K | -273.8% | $-4.5M | $-4.6M | $— | — |
| FY null | $225.0K | -229.8% | $-19.3M | $-20.8M | $— | — |
| Q3 null | $56.0K | -233.9% | $-5.0M | $-6.0M | $— | — |
| Q2 null | $68.0K | -260.3% | $-4.9M | $-3.9M | $— | — |
| Q1 null | $59.0K | -159.3% | $-4.9M | $-6.3M | $— | — |
| Q4 2023 | $95.0K | -146.3% | $-6.7M | $-4.9M | $-0.25 | — |